Biden Administration Announces Shift in Use of March-In Righ

Biden Administration Announces Shift in Use of March-In Rights for Drug Patents | Brooks Kushman P.C.

The Biden administration made a significant announcement today, December 7, 2023, marking a potential turning point in the way the U.S. government handles pharmaceutical patents. The...

Related Keywords

, White House National Economic Advisor Lael Brainard , Bayh Dole Act , House National Economic Advisor Lael Brainard , National Institute , Interagency Guidance Framework , March In Rights ,

© 2025 Vimarsana